HIV Meds Help Slash Infection Risk to Nearly Zero: Study
MONDAY, July 24, 2023 (HealthDay News) — People taking antiretroviral therapy to treat HIV who have low but detectable virus levels have almost zero risk of transmitting the virus to others, according to a new research review.Researchers looked at ei…
Learn MoreUn hombre europeo podría ser la sexta persona que se ‘cura’ del VIH
JUEVES, 20 de julio de 2023 (HealthDay News) — Es raro que una persona con VIH entre en remisión y se considere “curada”, pero un hombre europeo podría ser la sexta persona que lo logra. El hombre, que recibió un diagnóstico inicial de VIH en 1990, h…
Learn MoreEuropean Man May Be Sixth Person to Be ‘Cured’ of HIV
THURSDAY, July 20, 2023 (HealthDay News) — It is rare for someone with HIV to go into remission and be considered “cured,” but a European man may be the sixth to do so.First diagnosed with HIV in 1990, the man had been taking antiretroviral drugs sin…
Learn MoreEuropean Man May Be 6th Person to Be ‘Cured’ of HIV
THURSDAY, July 20, 2023 (HealthDay News) — It’s rare for someone with HIV to go into remission and be considered “cured,” but a European man may be the sixth to do so.First diagnosed with HIV in 1990, the man had been taking antiretroviral drugs sinc…
Learn MorePfizer advierte de una escasez de un antibiótico para la sífilis
VIERNES, 7 de julio de 2023 (HealthDay News) — Los expertos en enfermedades infecciosas advierten que una escasez de un antibiótico clave para tratar la sífilis, una infección de transmisión sexual, podría dificultar la lucha contra la propagación de…
Learn MorePfizer Warns of Shortage of Antibiotic Used to Fight Syphilis
FRIDAY, July 7, 2023 (HealthDay News) — Infectious disease experts are warning that a shortage of a key antibiotic for treating the sexually transmitted infection syphilis could make it hard to fight the spread of the disease.The United States alread…
Learn MoreUnos fármacos inyectados de acción prolongada para el VIH podrían ayudar a los pacientes difíciles de tratar
MIÉRCOLES, 5 de julio de 2023 (HealthDay News) — Durante casi tres décadas, las pastillas antirretrovirales diarias han ofrecido a los pacientes que viven con VIH una forma altamente efectiva de mantener su infección bajo control. Pero para algunos p…
Learn MoreLong-Acting ART Achieves Virologic Suppression for People With HIV
WEDNESDAY, July 5, 2023 (HealthDay News) — Long-acting antiretroviral therapy (LA-ART) can achieve virologic suppression among people with HIV (PWH), including those with viremia, according to a study published online July 4 in the Annals of Internal…
Learn MoreLong-Acting, Injected HIV Meds Can Help Tough-to-Treat Patients
WEDNESDAY, July 5, 2023 (HealthDay News) — For nearly three decades, daily antiretroviral pills have offered patients living with HIV a highly effective way to keep their infection under control.But some patients, particularly those beset by homeless…
Learn MoreQuizá pronto haya un implante de PrEP que proteja del VIH
JUEVES, 29 de junio de 2023 (HealthDay News) — Una investigación con animales apunta a una nueva forma de prevenir la infección con el VIH: un implante rellenable que administra de forma continua medicamentos antirretrovirales durante hasta 20 meses …
Learn More